[Role of a prolonged-action analog of somatostatin SMS 201-995 in the therapy of type 2 diabetes mellitus].
Candrina
R
R
Giustina
G
G
D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*
D001786:Blood Glucose; D002096:C-Peptide; D015282:Octreotide
Il ruolo dell'analogo a lunga durata d'azione della somatostatina SMS 201-995 nella terapia del diabete mellito di tipo II.